Carregant...

NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway

BACKGROUND: Salivary adenoid cystic carcinoma (SACC) can recur after removal of the primary tumor and treatment, where they can keep no clinical symptoms and dormant state for 10–15 years. NR2F1 has been demonstrated to regulate the tumor cell dormancy in various malignant tumors and has a potential...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Gao, Xiao-lei, Zheng, Min, Wang, Hao-fan, Dai, Lu-ling, Yu, Xiang-hua, Yang, Xiao, Pang, Xin, Li, Li, Zhang, Mei, Wang, Sha-sha, Wu, Jing-biao, Tang, Ya-Jie, Liang, Xin-hua, Tang, Ya-ling
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6664703/
https://ncbi.nlm.nih.gov/pubmed/31357956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5925-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!